Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

More on the 148 reexam

optymystic

Dec 17, 2009 01:28PM

Re: More on the 148 reexam

optymystic

Dec 17, 2009 02:17PM

optymystic

Rank: President [?]

Points: 18922 [?]

Votes: 159 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: More on the 148 reexam

in response to

Re: More on the 148 reexam

optymystic

posted on Dec 17, 2009 02:51PM

Well guess it should not surprise anyone that a rejection based on Bugala in view of Taimura is exactly the same argument that the examiner used previously.

Bugala in view of Taminura has already been argued! So, not sure anymore whether or not the examiner accepted our definition of processing unit included in the 3/27/09 response. He seems to have totally disregarded it, but is well aware of the claim amendments made at the same time. I guess Bizzare would be the appropriate term to describe the latest office action.

I guess we copy and paste the prior arguments for Kajigaya, Tanimura and Bugala.

GLTA, Opty

2 Recommendations